ClearPoint Neuro (CLPT) Other Non-Current Liabilities (2011 - 2026)

ClearPoint Neuro's (CLPT) quarterly Other Non-Current Liabilities came in at $779000.0 in Q1 2026, up 59.3% quarter-over-quarter from $489000.0 in Q4 2025.

ClearPoint Neuro (CLPT) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends

ClearPoint Neuro has disclosed Other Non-Current Liabilities across 11 years of filings, most recently posting $779000.0 for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $779000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $779000.0 (changed N/A YoY), and the FY2025 annual result was $489000.0, changed N/A from the prior year.
  • Other Non-Current Liabilities came in at $779000.0 for Q1 2026 at ClearPoint Neuro, up from $489000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $779000.0 in Q1 2026 to a low of $263000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 ClearPoint Neuro 524.46 Mn 488.86 Mn 7.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 779,000.00
Dec 31, 2025 489,000.00
Sep 30, 2025 263,000.00
Dec 31, 2019 960,000.00
Sep 30, 2019 934,829.00
Jun 30, 2019 910,000.00
Mar 31, 2019 892,125.00
Dec 31, 2018 857,500.00
Sep 30, 2018 839,625.00
Jun 30, 2018 805,000.00
Mar 31, 2018 787,125.00
Dec 31, 2017 79,286.00
Dec 31, 2016 647,500.00
Sep 30, 2016 657,351.00
Jun 30, 2016 715,125.00
Mar 31, 2016 577,125.00
Dec 31, 2015 542,500.00
Sep 30, 2015 524,625.00
Jun 30, 2015 490,000.00
Mar 31, 2015 962,075.00